Use of six-minute walking test to predict peak oxygen consumption in pulmonary vascular disease.
In recent years, exercise capacity has received increasing attention due to its use as a prognostic tool and its association with functional status in patients with pulmonary vascular diseases. For this reason, both distance walked in the 6‐min walking test (6MWD) and VO2peak are included in the ris...
| Autores: | , , |
|---|---|
| Formato: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2022 |
| País: | España |
| Recursos: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repositorio: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:recercat.cat:2445/209522 |
| Acesso em linha: | https://hdl.handle.net/2445/209522 |
| Access Level: | acceso abierto |
| Palavra-chave: | Malalties vasculars Malalties del pulmó Efectes fisiològics Exercici Vascular diseases Pulmonary diseases Physiological effect Exercise |
| Resumo: | In recent years, exercise capacity has received increasing attention due to its use as a prognostic tool and its association with functional status in patients with pulmonary vascular diseases. For this reason, both distance walked in the 6‐min walking test (6MWD) and VO2peak are included in the risk assessment table of the current clinical guidelines for PH. However, despite the validity of both tests, the CPET is the gold standard examination for assessing exercise capacity, even though it is an expensive test that requires a skilled operator and specialized equipment with limited availability. |
|---|